TokenPost topic

Pemvidutide

1 TokenPost story is tagged Pemvidutide. The newest appear first.

Latest Pemvidutide stories

• Altimmune Reports $480 Million in Cash as Third-Quarter Loss Widens

  The company expects 52-week results from its Phase 3 PERFORMA trial in 2029 and RESTORE data in the second half of 2027.

  Nov 12, 2026, 4:06 PM EST · Business